ESSILOR (EPA:EL) Disclosure of Share Capital and Voting Rights Outstanding as of June 30,2010
Transparency directive : regulatory news
06/07/2010 18:00
Click here to download pdf version
Regulatory Information
Disclosure of Share Capital and Voting Rights Outstanding as of June 30, 2010
(Pursuant to Article L.233-8 II of the French Commercial Code and articles
221-1 and 223-16 of the General Regulations of the Autorité des Marchés
Financiers)
Charenton-le-Pont, France (July 6, 2010 - 06:00 pm) - As of June 30, shares and
voting rights outstanding of Essilor, the world leader in ophthalmic optics,
broke down as follows:
June 30, 2010
Shares outstanding 212,847,382
Exercisable voting rights 227,558,400
Total potential voting rights, including rights attached to
shares held in treasury and under the liquidity contract. 230,994,850
The world leader in ophthalmic optical products, Essilor International
researches, develops, manufactures and markets around the world a wide range of
lenses to correct myopia, hyperopia, presbyopia and astigmatism. Its flagship
brands are Varilux(r), Crizal(r), Essilor(r), Definity(r) and Xperio(TM).
Based in France, the company reported consolidated revenue of EUR3.2 billion in
2009, with 34,700 employees and operations in 100 countries.
For more information, please visit www.essilor.com.
The Essilor share trades on the NYSE Euronext Paris market and is included in
the CAC 40 index. Codes and symbols: ISIN: FR FR0000121667; Reuters: ESSI.PA;
Bloomberg: EI:FP.
Investor Relations and Financial Communications
www.essilor.com
Phone: +33 (0)1 49 77 42 16